SEOM clinical guidelines for the treatment of head and neck cancer

Clinical and Translational Oncology

Volumn 12, Issue 11, 2010, Pages 742-748

  Mesía Nin, Ricard ^d   Pastor Borgoñón, Miguel ^a   Cruz Hernández, Juan Jesús ^b   Isla Casado, Dolores ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d NONE

Author keywords

Concomitant chemo radiotherapy; Head and neck cancer; Induction chemotherapy; Radiotherapy

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE; FLUOROURACIL; PACLITAXEL;

ANAMNESIS; BREATHING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISTANT METASTASIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; LARYNGECTOMY; LASER SURGERY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ODONTOLOGY; OTOTOXICITY; PHONATION; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; REVIEW; SQUAMOUS CELL CARCINOMA; SWALLOWING; THORAX RADIOGRAPHY; TUMOR BIOPSY;

EID: 78649638453     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0589-2     Document Type: Review

References (19)

1. J. Borras J.M. Borras J. Galcerán, et al. 2001 Tendencia del cáncer relacionado con el tabaco en Tarragona, España, 1980-96 Cancer Causes Control 12 903 908 1:STN:280:DC%2BD38%2Fot1Glsg%3D%3D 10.1023/A:1013764220293 11808709 (Pubitemid 34048871)
2. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5, version 2.0. IARC Press, Lyon
3. TNM Classification (2002) In: AJCC Cancer Staging Manual, 6th edn. Springer, New York, NY
4. A. Forastiere W. Koch A. Trotti D. Sidransky 2001 Head and neck cancer N Engl J Med 345 1890 1900 1:STN:280:DC%2BD38%2FlvFektA%3D%3D 10.1056/NEJMra001375 11756581
5. E. Winquist T. Oliver R. Gilvert 2007 Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis Head Neck 29 38 46 10.1002/hed.20465 17103410 (Pubitemid 46032565)
6. J.P. Pignon J. Bourhis C. Domenge L. Designé 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data Lancet 355 949 955 1:STN:280:DC%2BD3c3ivV2iuw%3D%3D 10768432
7. J.A. Bonner P.M. Harari J. Giralt, et al. 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 567 578 1:CAS:528:DC%2BD28Xhtleksbs%3D 10.1056/NEJMoa053422 16467544 (Pubitemid 43209104)
8. J.A. Bonner P.M. Harari J. Giralt, et al. 2009 Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 21 28 10.1016/S1470-2045(09)70311-0 19897418
9. J.B. Vermorken E. Remenar C. Van Herpen, et al. 2007 Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. Phase III trial EORTC 24971/TAX 323 N Engl J Med 357 1695 1704 1:CAS:528:DC%2BD2sXht1ansLvP 10.1056/NEJMoa071028 17960012 (Pubitemid 350005151)
10. M.R. Posner D.M. Hershock C.R. Blajman, et al. 2007 Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer TAX 324StudyGroup.NEnglJMed357 1705 1725
11. J.L. Lefebvre K.K. And 2009 Larynx preservation clinical trial design: key issues and recommendations. A consensus panel summary Int J Radiat Oncol Biol Phys 73 1293 1303 19306746
12. (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685-1690
13. A.A. Forastiere H. Goepfert M. Maor, et al. 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 2098 1:CAS:528:DC%2BD3sXptlKiu7s%3D 10.1056/NEJMoa031317 14645636 (Pubitemid 37464533)
14. A.A. Forastiere M. Maor R.S. Weber, et al. 2006 Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx. Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy J Clin Oncol 24[18S] 5517
15. Y. Pointreau P. Garuad S. Chapet, et al. 2009 Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 498 506 1:CAS:528:DC%2BD1MXktFWrtbc%3D 10.1093/jnci/djp007 19318632
16. J.A. Bonner M. Harare J. Giralt, et al. 2005 Improved preservation of larynx with the addition of cetuximab to radiotherapy for cancers of the larynx and hypopharynx J Clin Oncol 23 [16S] 5533
17. R. Hitt A. López-Pousa J. Martínez-Trufero, et al. 2005 Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 23 8636 8645 10.1200/JCO.2004.00. 1990 16275937 (Pubitemid 46211506)
18. J.B. Vermorken R. Mesia F. Rivera, et al. 2008 Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 1116 1127 1:CAS:528:DC%2BD1cXhtFWrsrnI 10.1056/NEJMoa0802656 18784101
19. R. Hitt A. Irigoyen J. Nuñez, et al. 2007 Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC) J Clin Oncol 25 [18S] 6012